OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastrointestinal problems, and tooth decay. They are sold through hospitals, pharmaceutical stores, grocery stores, catalogs, and online retail stores.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: OTC drugs: An overview

Regulatory pathways for OTC approval

FDA OTC drug approval process

Strategies to penetrate OTC pharmaceuticals in

emerging markets

PART 06: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 07: Market segmentation by therapeutic class

PART 08: Global respiratory OTC drugs market

Market overview

PART 09: Global dietary supplements market

Market overview

PART 10: Global gastrointestinal OTC drugs market

Market overview

Market segmentation by therapeutic class of drug

PART 11: Global OTC pain medications market

Market overview

Market segmentation by therapeutic class of drug

PART 12: Market segmentation by route of

administration

Oral

Topical

Parenteral

PART 13: Geographical segmentation

Global OTC drugs market by geography 2015-2020

OTC drugs market in Americas

OTC drugs market in US

OTC drugs market in EMEA

OTC drugs market in Germany

OTC drugs market in France

OTC drugs market in APAC

OTC drugs market in China

OTC drugs market in Japan

OTC drugs market in India

PART 14: Market drivers

Switching of medications from prescription to OTC

Lenient regulatory framework and distribution channel

Cost-effective OTC drugs

Rise in self-medication

PART 15: Impact of drivers

PART 16: Market challenges

Counterfeit drugs

Lack of valid literature

High expenditure on advertisements

PART 17: Impact of drivers and challenges

PART 18: Market trends

Accelerated use of online resources

Promotions and marketing initiatives

Strategic alliances

PART 19: Vendor landscape

Competitive scenario

PART 20: Key vendor analysis

GSK

Johnson & Johnson

Pfizer

Bayer HealthCare

Sanofi

Other prominent vendors

PART 21: Appendix

List of abbreviations

PART 22: Explore Technavio